68 related articles for article (PubMed ID: 22097930)
21. Radiomics: extracting more information from medical images using advanced feature analysis.
Lambin P; Rios-Velazquez E; Leijenaar R; Carvalho S; van Stiphout RG; Granton P; Zegers CM; Gillies R; Boellard R; Dekker A; Aerts HJ
Eur J Cancer; 2012 Mar; 48(4):441-6. PubMed ID: 22257792
[TBL] [Abstract][Full Text] [Related]
22. Cholangiocarcinoma imaging: from diagnosis to response assessment.
Cao J; Srinivas-Rao S; Mroueh N; Anand R; Kongboonvijit S; Sertic M; Shenoy-Bhangle AS; Kambadakone A
Abdom Radiol (NY); 2024 May; 49(5):1699-1715. PubMed ID: 38578323
[TBL] [Abstract][Full Text] [Related]
23. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
Taher MY; Hassouna EM; El-Hadidi AS; El-Aassar OS; Bakosh MF
J Gastrointest Cancer; 2024 Jun; 55(2):749-758. PubMed ID: 38231289
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of cholangiocyte phenotype hepatocellular carcinoma on contrast-enhanced MRI and the prognostic implication after hepatectomy.
Chen Y; Chen J; Yang C; Wu Y; Wei H; Duan T; Zhang Z; Long L; Jiang H; Song B
Insights Imaging; 2023 Nov; 14(1):190. PubMed ID: 37962669
[TBL] [Abstract][Full Text] [Related]
25. Radiomics nomogram for prediction of glypican-3 positive hepatocellular carcinoma based on hepatobiliary phase imaging.
Zhang N; Wu M; Zhou Y; Yu C; Shi D; Wang C; Gao M; Lv Y; Zhu S
Front Oncol; 2023; 13():1209814. PubMed ID: 37841420
[TBL] [Abstract][Full Text] [Related]
26. Radiologic features of hepatocellular carcinoma related to prognosis.
Hwang SH; Rhee H
J Liver Cancer; 2023 Mar; 23(1):143-156. PubMed ID: 37384030
[TBL] [Abstract][Full Text] [Related]
27. The added value of
Lv J; Yin H; Yu H; Shi H
Abdom Radiol (NY); 2023 Jul; 48(7):2331-2339. PubMed ID: 37119293
[TBL] [Abstract][Full Text] [Related]
28. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
Yoon JK; Choi JY; Rhee H; Park YN
Eur Radiol; 2022 Aug; 32(8):5119-5133. PubMed ID: 35258675
[TBL] [Abstract][Full Text] [Related]
29. Gd-EOB-DTPA-enhanced magnetic resonance imaging may help identify patients with hepatocellular carcinoma eligible for treatment targeted at RAF1.
Mo Z; Ding H; Zhou X; Zeng Z; Long L
Abdom Radiol (NY); 2022 Jan; 47(1):209-220. PubMed ID: 34738148
[TBL] [Abstract][Full Text] [Related]
30. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
Front Oncol; 2021; 11():672126. PubMed ID: 34476208
[TBL] [Abstract][Full Text] [Related]
31. MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma.
Zhou C; Ni X; Lu X; Wang Y; Qian X; Yang C; Zeng M
J Hepatocell Carcinoma; 2021; 8():975-983. PubMed ID: 34458204
[TBL] [Abstract][Full Text] [Related]
32. Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.
Moon JY; Min JH; Kim YK; Cha D; Hwang JA; Ko SE; Choi SY; Yun EJ; Kim SW; Won HJ
Korean J Radiol; 2021 Nov; 22(11):1786-1796. PubMed ID: 34402243
[TBL] [Abstract][Full Text] [Related]
33. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
[TBL] [Abstract][Full Text] [Related]
34. Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression.
Rhee H; Kim H; Park YN
Liver Cancer; 2020 Dec; 9(6):663-681. PubMed ID: 33442539
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients.
Cha DI; Jang KM; Kim SH; Kim YK; Kim H; Ahn SH
Korean J Radiol; 2020 Apr; 21(4):402-412. PubMed ID: 32193888
[TBL] [Abstract][Full Text] [Related]
36. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
Chen J; Wu Z; Xia C; Jiang H; Liu X; Duan T; Cao L; Ye Z; Zhang Z; Ma L; Song B; Shi Y
Eur Radiol; 2020 Feb; 30(2):1232-1242. PubMed ID: 31529254
[TBL] [Abstract][Full Text] [Related]
38. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
Kim JH; Joo I; Lee JM
Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features.
Rhee H; An C; Kim HY; Yoo JE; Park YN; Kim MJ
Liver Cancer; 2019 Feb; 8(1):24-40. PubMed ID: 30815393
[TBL] [Abstract][Full Text] [Related]
40. Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.
Kagen A; Fowler K; Sirlin CB
Hepat Oncol; 2014 Jan; 1(1):95-105. PubMed ID: 30190944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
